<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01114724</url>
  </required_header>
  <id_info>
    <org_study_id>IP # 118</org_study_id>
    <nct_id>NCT01114724</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections</brief_title>
  <official_title>Valiant® Thoracic Stent Graft With the Captivia Delivery System. Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Endovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Endovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the Valiant stent graft is safe and effective in
      treating patients who have a thoracic dissection. A thoracic dissection is a tear in the wall
      of the aorta, that causes blood to flow between the layers of the aorta and force the layers
      apart (dissect). This condition is a medical emergency and can quickly lead to death. Since
      stent grafting has been an effective way to treat other aortic conditions such as aneurysms
      (bulge in aorta wall), it is believed that the device would be effective in treating
      dissections. Information will be collected on the performance of the device for 5 years.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All Cause Mortality.</measure>
    <time_frame>Up to 30 days after the stent graft implant.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause Mortality</measure>
    <time_frame>at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects With Successful Delivery and Deployment of the Device.</measure>
    <time_frame>At implant.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects With Coverage of Primary Tear</measure>
    <time_frame>At implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Rupture</measure>
    <time_frame>Within 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Rupture</measure>
    <time_frame>Within 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects With Secondary Endovascular Procedures</measure>
    <time_frame>Through12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Remodeling: Subjects With Partial/Complete False Lumen Thrombosis Over the Stented Segment</measure>
    <time_frame>At 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Remodeling: Subjects With Complete/Partial Thrombosis of the False Lumen Over the Stented Segment</measure>
    <time_frame>At 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Increase in True Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</measure>
    <time_frame>at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Increase in True Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</measure>
    <time_frame>at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Decrease in False Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</measure>
    <time_frame>at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Decrease in False Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</measure>
    <time_frame>at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects With Device, Procedure and/or Aortic Related Serious Adverse Events.</measure>
    <time_frame>at 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects With Device, Procedure and/or Aortic Related Serious Adverse Events.</measure>
    <time_frame>at 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Aortic Dissection</condition>
  <arm_group>
    <arm_group_label>Valiant Thoracic Stent Graft with the Captivia Delivery System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Valiant Thoracic Stent Graft with the Captivia Delivery System</intervention_name>
    <description>All subjects will be implanted with this device</description>
    <arm_group_label>Valiant Thoracic Stent Graft with the Captivia Delivery System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Subject signed an informed consent.

          -  Subject is at least 18 years old.

          -  Subject has an acute, complicated Type B aortic dissection with evidence of at least
             one of the following:

          -  Malperfusion (visceral, renal, spinal cord and/or lower limb ischemia)

          -  Visceral ischemia measured by either radiographic or clinical evidence.

          -  Renal ischemia measured by either radiographic or clinical evidence.

          -  Spinal cord ischemia measured by either radiographic or clinical evidence.

          -  Lower limb ischemia measured by either radiographic or clinical evidence.

          -  Rupture - Measured by radiographic or clinical evidence.

          -  Subject is hemodynamically stable.

          -  Subject's anatomy must meet all of the following anatomical criteria:

        Proximal landing zone aortic diameter must be between 20 mm and 44 mm;

          -  Centerline distance from distal margin of left CCA or in cases of bovine anatomy,
             innominate artery, to start of most proximal tear must be ≥ 20 mm;

          -  Subject has patent iliac or femoral arteries or can tolerate an iliac conduit that
             allows endovascular access to the dissection site with the delivery system of the
             appropriate sized device.

          -  Thoracic aortic dissection is confirmed, at a minimum, by diagnostic contrast-enhanced
             computerized tomography angiogram (CTA) with 3-D reconstruction, and/or contrast
             enhanced magnetic resonance angiogram (MRA) obtained prior to the implant procedure.

        Exclusion Criteria

          -  Planned placement of the COVERED portion of the stent graft over the left carotid
             artery, or the celiac trunk.

          -  Subject has systemic infection.

          -  Subject is pregnant.

          -  Subject has received a previous stent or stent graft or previous surgical repair in
             the DTA.

          -  Subject has had a cerebral vascular accident (CVA) within 2 months.

          -  Subject has a history of bleeding diathesis, coagulopathy, or refuses blood
             transfusion.

          -  Subject has a history of Marfan Syndrome or other connective tissue disorder.

          -  Subject is currently participating in an investigational drug or device clinical trial
             which would interfere with the endpoints and follow-ups of this study.

          -  Subject has a known allergy or intolerance to the device components.

          -  Subject has a known hypersensitivity or contraindication to anticoagulants or contrast
             media, which is not amenable to pre-treatment.

          -  Subject has a co-morbidity causing expected survival to be less than 1 year.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph E. Bavaria, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ. of Pennsylvania Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>W. Anthony Lee, M.D., F.A.C.S</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lynn Heart Institute, Boca Raton Community Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>USC Keck School of Medicine</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbor UCLA</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Hospital D.C.</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Weill Cornell</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Heart and Vascular Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Hospital Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Heart and Vascular Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University MCV Richmond</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2010</study_first_submitted>
  <study_first_submitted_qc>April 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2010</study_first_posted>
  <results_first_submitted>May 30, 2014</results_first_submitted>
  <results_first_submitted_qc>May 30, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 3, 2014</results_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thoracic dissection</keyword>
  <keyword>Endovascular aortic repair</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
          <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
          <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.2" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>All Cause Mortality.</title>
        <time_frame>Up to 30 days after the stent graft implant.</time_frame>
        <population>Based on number of ITT subjects with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>All Cause Mortality.</title>
          <population>Based on number of ITT subjects with available data</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-cause Mortality</title>
        <time_frame>at 12 months</time_frame>
        <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn before the lower limit of the 12 months follow-up window or were lost to follow-up before the lower limit of the 12 months follow-up window. (One patient withdrew and one was lost to follow-up)</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Mortality</title>
          <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn before the lower limit of the 12 months follow-up window or were lost to follow-up before the lower limit of the 12 months follow-up window. (One patient withdrew and one was lost to follow-up)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects With Successful Delivery and Deployment of the Device.</title>
        <time_frame>At implant.</time_frame>
        <population>Based on number of ITT subjects with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects With Successful Delivery and Deployment of the Device.</title>
          <population>Based on number of ITT subjects with available data</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects With Coverage of Primary Tear</title>
        <time_frame>At implant</time_frame>
        <population>Based on number of ITT subjects with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects With Coverage of Primary Tear</title>
          <population>Based on number of ITT subjects with available data</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Rupture</title>
        <time_frame>Within 30 days</time_frame>
        <population>Based on number of ITT subjects with available data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft will the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Rupture</title>
          <population>Based on number of ITT subjects with available data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Rupture</title>
        <time_frame>Within 12 months</time_frame>
        <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn before the lower limit of the 12 months follow-up window or were lost to follow-up before the lower limit of the 12 months follow-up window. (One patient withdrew and one was lost to follow-up)</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Rupture</title>
          <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn before the lower limit of the 12 months follow-up window or were lost to follow-up before the lower limit of the 12 months follow-up window. (One patient withdrew and one was lost to follow-up)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects With Secondary Endovascular Procedures</title>
        <time_frame>Through12 months</time_frame>
        <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn before the lower limit of the 12 months follow-up window or were lost to follow-up before the lower limit of the 12 months follow-up window. (One patient withdrew and one was lost to follow-up)</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects With Secondary Endovascular Procedures</title>
          <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn before the lower limit of the 12 months follow-up window or were lost to follow-up before the lower limit of the 12 months follow-up window. (One patient withdrew and one was lost to follow-up)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Remodeling: Subjects With Partial/Complete False Lumen Thrombosis Over the Stented Segment</title>
        <time_frame>At 6 months</time_frame>
        <population>Based on number of ITT subjects with evaluable imaging data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Remodeling: Subjects With Partial/Complete False Lumen Thrombosis Over the Stented Segment</title>
          <population>Based on number of ITT subjects with evaluable imaging data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Remodeling: Subjects With Complete/Partial Thrombosis of the False Lumen Over the Stented Segment</title>
        <time_frame>At 12 months</time_frame>
        <population>Based on number of ITT subjects with evaluable imaging data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Remodeling: Subjects With Complete/Partial Thrombosis of the False Lumen Over the Stented Segment</title>
          <population>Based on number of ITT subjects with evaluable imaging data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Increase in True Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
        <time_frame>at 6 months</time_frame>
        <population>Based on number of ITT subjects with evaluable imaging data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Increase in True Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
          <population>Based on number of ITT subjects with evaluable imaging data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Increase in True Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
        <time_frame>at 12 months</time_frame>
        <population>Based on number of ITT subjects with evaluable imaging data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Increase in True Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
          <population>Based on number of ITT subjects with evaluable imaging data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Decrease in False Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
        <time_frame>at 6 months</time_frame>
        <population>Based on number of ITT subjects with evaluable imaging data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Decrease in False Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
          <population>Based on number of ITT subjects with evaluable imaging data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Decrease in False Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
        <time_frame>at 12 months</time_frame>
        <population>Based on number of ITT subjects with evaluable imaging data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Remodeling: Subjects With Stable (+/- 5mm) or Decrease in False Lumen (&gt;5mm) Compared to First Post-procedural CT Over the Stent Graft</title>
          <population>Based on number of ITT subjects with evaluable imaging data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects With Device, Procedure and/or Aortic Related Serious Adverse Events.</title>
        <time_frame>at 30 days</time_frame>
        <population>Based on number of ITT subjects with available data.</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects With Device, Procedure and/or Aortic Related Serious Adverse Events.</title>
          <population>Based on number of ITT subjects with available data.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects With Device, Procedure and/or Aortic Related Serious Adverse Events.</title>
        <time_frame>at 12 months</time_frame>
        <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn or were lost to follow-up before the lower limit of the 12 mos follow-up window.One subject was lost to follow-up and one withdrew before 12 mos. One of these subjects experienced an AE before study exit and was included in the analysis,</population>
        <group_list>
          <group group_id="O1">
            <title>Valiant Thoracic Stent Graft With the Captivia Delivery System</title>
            <description>Valiant Thoracic Stent Graft with the Captivia Delivery System: All subjects will be implanted with this device</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects With Device, Procedure and/or Aortic Related Serious Adverse Events.</title>
          <population>Based on number of ITT subjects with available data. Subjects were considered unevaluable if they were withdrawn or were lost to follow-up before the lower limit of the 12 mos follow-up window.One subject was lost to follow-up and one withdrew before 12 mos. One of these subjects experienced an AE before study exit and was included in the analysis,</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>1. Dissection</title>
          <description>Medtronic Dissection</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 10.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Intestinal Ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Continued Perfusion from a Branch Vessel requiring Treatment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Incision Site Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Nerve Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Stent-Graft Endoleak</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>White Blood Cell Count Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral Ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Monoplegia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Spinal Cord Ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title vocab="MedDRA (10.0)">Paraplegia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic Aneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Aortic Dissection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Intermittent Claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Subclavian Artery Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Principal Investigator (PI) and institution agree not to publish the results of the study until after the earliest of the following: a)conclusion of the study, b)the early termination of the study, c)at discretion and approval of the sponsor, or d)after sponsor confirms there will be no multicenter study publication, whichever occurs first. PI and institution further agree to submit to sponsor copies of any proposed publication or public presentation at least sixty days before dissemination.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Laura Regan, MPH - Study Lead</name_or_title>
      <organization>Medtronic Inc., Aortic and Peripheral Vascular</organization>
      <phone>707-591-2743</phone>
      <email>laura.e.regan@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

